Although they note that their risk combination model needs validation, investigators argue that their insights should guide recommendations for risk stratification and management of these patients.
A trio of parameters with potential to help risk stratify pediatric patients with pulmonary arterial hypertension (PAH) have been identified by the researchers of a new study published in Journal of the American Heart Association. PAH, the investigators wrote, is associated with high morbidity and mortality in children.
The simple risk stratification score can be determined bedside without the need for a computer, explained the researchers. Although they note that their risk combination model needs validation, the group argues that these insights should guide recommendations for risk stratification and management of these patients.
“A major challenge to treating physicians is the lack of robust risk stratification tools, allowing clinicians to guide therapy and direct high-risk patients to parenteral prostanoid therapy and consideration of lung transplantation,” wrote the researchers. “While noninvasive assessment tools exist, transthoracic echocardiography remains the most important modality in the routine regular assessment of patients, including 6-minute walk test distance and natriuretic peptide levels.”
The researchers included 63 patients in their study, all of whom had PAH and a biventricular cardiac anatomy without relevant shunt lesions. All patients underwent a standardized transthoracic echocardiography and came from a single center in London between 2005 and 2013. Over a median of 4.1 years of follow-up, 17 patients died and 4 underwent lung transplantation.
Results show that a combination of right atrial (RA) area, left ventricular (LV) eccentricity index, and tricuspid annual plane excursion—a group of widely available parameters—could serve as a simple score to determine prognosis. Analysis showed the 3 parameters were all independent predictors of mortality.
The researchers highlighted that the combination offers information on different physiological consequences of PAH. For example, RA distention may be a result of various processes, making it a composite biomarker, and LV eccentricity index is a quantitative description of interventricular septal deviation.
“Perhaps surprisingly, however, we found RA area and LV eccentricity index to have superior discriminative ability and to be more robust compared with tricuspid annular plane excursion [TAPSE], especially for the combined end point, even when TAPSE was adjusted for children’s age in our cohort,” detailed the researchers. “When mortality alone was considered as an end point, however, TAPSE emerged as an independent predictor of outcome and should thus be considered as an adjunct in the risk stratification process.”
Using a combination of the parameters, the researchers created a risk prediction model following a flow chart design, which differentiated patients by prognosis. They note that the prediction model needs external validation.
The researchers also noted that strain measurements were not included in their analysis, with future research needed to determine their potential prognostic value.
Reference
Lammers AE, Marek J, Diller G-P, Haworth SG, Moledina S. Prognostic value of transthoracic echocardiography in children with pulmonary arterial hypertension. J Am Heart Assoc. Published online March 21, 2023. doi:10.1161/JAHA.121.023118
Contributor: For Complex Cases, Continuity in Acute Care Is Necessary
April 23rd 2025For patients with complex needs and social challenges like unstable housing, the hospital has become their de facto medical home—yet each visit is a fragmented restart, without continuity, context, or a clear path forward.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More